CytoDyn Inc. (OTCMKTS:CYDY) Sees Significant Growth in Short Interest

CytoDyn Inc. (OTCMKTS:CYDY - Get Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 20,123,400 shares, a growth of 15.0% from the December 15th total of 17,499,100 shares. Based on an average daily trading volume, of 6,176,200 shares, the short-interest ratio is currently 3.3 days.

CytoDyn Stock Up 1.3 %

CYDY traded up $0.00 during trading on Friday, hitting $0.15. The company had a trading volume of 1,217,001 shares, compared to its average volume of 2,325,929. The company has a market capitalization of $185.14 million, a PE ratio of -7.54 and a beta of -0.10. CytoDyn has a one year low of $0.10 and a one year high of $0.32. The firm's 50-day moving average price is $0.12 and its 200 day moving average price is $0.14.

About CytoDyn

CytoDyn Inc, a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer.